Related Experiment Video
Updated: Apr 11, 2026

06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.9K
Breaking down barriers to communicating complex retinoblastoma information: can graphics be the solution?
Hannah H Chiu1, Helen Dimaras2, Rob Downie3
1Department of Ophthalmology and Vision Sciences, Faculty of Medicine, University of Toronto.
Summary
Parents using the Disease-Specific electronic Patient Illustrated Clinical Timeline (DePICT) tool showed good understanding of complex retinoblastoma treatment options. This visual aid can improve the informed consent process for families facing this rare eye cancer.
Area of Science:
- Pediatric Oncology
- Ophthalmology
- Medical Informatics
Background:
- Retinoblastoma is a rare pediatric eye cancer requiring complex treatment decisions.
- Effective communication of medical information is crucial for parental understanding and informed consent.
Purpose of the Study:
- To evaluate the impact of a graphical timeline, the Disease-Specific electronic Patient Illustrated Clinical Timeline (DePICT), on parents' comprehension of bilateral retinoblastoma treatment.
- To assess the effectiveness of DePICT in communicating complex medical information to parents.
Main Methods:
- A cross-sectional survey was conducted with 45 parents of children with retinoblastoma.
- Participants received a standardized presentation on retinoblastoma and the DePICT tool.
- A 19-item questionnaire assessed parents' understanding of treatment choices for bilateral retinoblastoma using DePICT.
Main Results:
- Parents achieved a median score of 15 out of 19 correct answers (77% mean score) on the understanding questionnaire.
- English as a first language was significantly associated with higher scores (p = 0.01).
- No other demographic variables showed a significant association with comprehension scores.
Conclusions:
- The DePICT tool facilitates good comprehension of complex retinoblastoma treatment options for parents, even for bilateral cases.
- Clinical implementation of DePICT can enhance the patient-physician communication and informed consent process.
Related Concept Videos
The Retinoblastoma Gene
5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
The Retinoblastoma Gene
2.9K
2.9K

